NDC 57664-953 – Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate

Dextroamphetamine Saccharate 12.5 mg/1; Amphetamine Aspartate Monohydrate 12.5 mg/1; Dextroamphetamine Sulfate 12.5 mg/1; Amphetamine Sulfate 12.5 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC57664-953

Product details

Brand name
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
Generic name
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA215997
Marketed since
February 1, 2024
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
57664-953-88100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (57664-953-88)Feb 1, 2024

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products